• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

December 3, 2024

FDA Blocks Flavored E-Cigarettes, Sparking Legal Fight Over Risks to Minors

Author(s):

Alexandra Gerlach, Associate Editor

E-cigarette manufacturers claim the products aid in smoking cessation for adults without the risk of adolescent usage.

The FDA blocked the approval of flavored e-cigarettes, causing controversy amongst the Supreme Court and manufacturers with petitions citing the agency’s failure to follow proper legal procedures when rejecting the applications. This led to a lawsuit from multiple e-cigarette manufacturers who claim the FDA unfairly changed its requirements without enough warning.1

Colored e-cigarettes | Image Credit: © iama_sing - stock.adobe.com

Colored e-cigarettes | Image Credit: © iama_sing - stock.adobe.com

"FDA switched its position on what studies were required to show that the products have benefits to existing smokers that offset risks to youth,” said Eric Heyer, an attorney representing the manufacturers Triton Distribution and Vapetasia.1

The FDA began the regulation of cigarettes in the 1990s, driving rates of underage smoking to 2%. However, the rise of e-cigarettes, or vapes, has filled the gap left behind by decreasing rates of cigarette use. This is largely driven by the misconception that e-cigarettes do not have the same contaminants and carcinogens found in traditional tobacco cigarettes. Many individuals, as a result, have transitioned to use of e-cigarettes as an alternative or as a tool for smoking cessation.2,3

E-cigarettes, according to American Heart Association, are not safer than cigarettes and are made with many harmful substances including nicotine, which can impact learning, memory, and attention in developing adolescents. Additionally, these products often contain diacetyl, which has been linked to serious lung disease. Despite these risks, use continues to increase amongst adults, particularly adolescents, raising the concern that smoking may be “re-normalized” and decades of global efforts to reduce smoking could be undermined.3

In 2023, more than 2.1 million adolescents self-reported use of e-cigarettes, including 10% of high school students, of which 26.3% use the product daily. Experts and health care providers have continuously raised concerns about the marketing of flavored e-cigarettes, claiming they are more appealing to minors. Under a 2009 federal law, the FDA is required to control the use of tobacco and nicotine products used by adolescents. Over the years, the agency has repeatedly barred the marketing and distribution of various flavored e-cigarettes over concerns of risks to public health.2

Since the FDAs denial of approval for e-cigarette products, multiple companies have spoken out against the decision, claiming the agency unfairly disregarded arguments that flavored e-cigarette products help adults quit smoking tradition cigarettes without the risk to adolescents. Additionally, they claim the FDA changed its requirements in the middle of the approval process, leaving manufacturers without a sufficient warning. Despite this, the FDA remains firm in its position about the risk of flavored e-cigarettes on public health.4

"That is their argument," said Curtis Gannon, a lawyer from the Biden administration representing the FDA. "But I think that the key point is that they knew from the statute that they needed to be making this comparison about what the benefits were with respect to existing smokers and weighing that against the potential costs with respect to nonsmokers and attracting youth."1

Supreme Court justices Elena Kagan, Ketanji Brown Jackson, and Brett Kavanaugh support the FDAs decision, citing little surprise over the denial of approval for flavored e-cigarette products.1

"I guess I'm not really seeing what the surprise is here, or what the change is here," said Kagan. "There's just not a lot of mystery here about what FDA was doing. You might disagree with that, because you think that, in fact, the world of 40-year-olds really wants to do blueberry vaping, but you can't say that FDA hasn't told you all about what it's thinking in this respect."1

Despite the confirmed dangers of these products, they remain widely available to consumers. Should the supreme court side with the FDA, e-cigarette manufacturers maintain the opportunity to reapply for approval. However, it can be speculated that the FDA will continue its stance that flavored e-cigarette products pose a significant public health risk to minors.

REFERENCES
1. Supreme court divided over fda block on kid-friendly flavored vapes. ABC News. December 2, 2024, Accessed December 3, 2024. https://abcnews.go.com/Politics/supreme-court-weighs-fda-block-kid-friendly-flavored/story?id=116232703
2. FDA battles vaping industry at the supreme court. NPR. December 2, 2024. Accessed December 3, 2024. https://www.npr.org/2024/12/02/nx-s1-5205471/fda-vaping-supreme-court
3. Is vaping better than smoking. American Heart Association. January 5, 2024. Accessed December 3, 2024. https://www.heart.org/en/healthy-living/healthy-lifestyle/quit-smoking-tobacco/is-vaping-safer-than-smoking
4. Supreme court grapples with FDA's refusal to approve flavored vapes. NBC News. December 2, 2024. Accessed December 3, 2024. https://www.nbcnews.com/politics/supreme-court/supreme-court-hears-fight-fdas-refusal-approve-flavored-vapes-rcna182018

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: komokvm | stock.adobe.com
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Yellow ribbon for sarcoma awareness -- Image credit: Jo Panuwat D | stock.adobe.com
Related Content
Advertisement
Doctor holding bladder model | Image Credit: © M+Isolation+Photo - stock.adobe.com
June 12th 2025

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Alexandra Gerlach, Associate Editor
MEDcast logo
August 16th 2024

Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust with Parents

Trisha Winroth, PharmD Ashly McPhillips, PharmD
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting
March 21st 2024

Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

Young woman suffering from chronic pain | Image Credit: © Goffkein - stock.adobe.com
June 10th 2025

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Alexandra Gerlach, Associate Editor
Mom makes inhalation of the child, holding hands - Image credit: komokvm | stock.adobe.com
Published: June 9th 2025 | Updated: June 10th 2025

Clesrovimab Receives FDA Approval for RSV Lower Respiratory Tract Prevention in Infants

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Doctor holding bladder model | Image Credit: © M+Isolation+Photo - stock.adobe.com
June 12th 2025

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Alexandra Gerlach, Associate Editor
MEDcast logo
August 16th 2024

Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust with Parents

Trisha Winroth, PharmD Ashly McPhillips, PharmD
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting
March 21st 2024

Public Health Matters: Seacrest Studios’ Impact on Children’s Hospitals and Healing Through Broadcasting

Young woman suffering from chronic pain | Image Credit: © Goffkein - stock.adobe.com
June 10th 2025

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Alexandra Gerlach, Associate Editor
Mom makes inhalation of the child, holding hands - Image credit: komokvm | stock.adobe.com
Published: June 9th 2025 | Updated: June 10th 2025

Clesrovimab Receives FDA Approval for RSV Lower Respiratory Tract Prevention in Infants

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.